NRP1 and Patent ductus arteriosus: We sought to determine whether PDA interrupted the vascular endothelial barrier through the NRP1/VEGFR2/VE-Cad signaling pathway, and we knocked down NRP1 in HUVECs following PDA treatment and performed real-time PCR to evaluate transcription levels of inflammation-related genes.